RIVIECCIO, ANTONIA
RIVIECCIO, ANTONIA
Apremilast as a Potential Targeted Therapy for Metabolic Syndrome in Patients with Psoriasis: An Observational Analysis
2024-01-01 Campione, E; Zarabian, N; Cosio, T; Borselli, C; Artosi, F; Cont, R; Sorge, R; GAETA SHUMAK, R; Costanza, G; Rivieccio, A; Gaziano, R; Bianchi, L
Bimekizumab for the treatment of moderate to severe psoriasis: a real-world experience over 52 weeks from two Italian dermatology clinics
2025-12-01 Mortato, E; Artosi, F; Borselli, C; Compagnucci, I; Rivieccio, A; Lanna, C; Lambiase, S; Gaeta Shumak, R; Loconsole, F; Bianchi, L; Campione, E
Clinical and ultrasound efficacy of topical hypertonic cream (Jovita Osmocell®) in the treatment of cellulite: a prospective, monocentric, double-blind, placebo-controlled study
2024-05-08 Di Guardo, A; Solito, C; Cantisani, V; Rega, F; Gargano, L; Rossi, G; Musolff, N; Azzella, G; Paolino, G; Losco, L; Rivieccio, A; Campione, E; Bianchi, L; Nisticò, Sp; Pellacani, G; Cantisani, C
Preliminary Evidence of Efficacy, Safety, and Treatment Satisfaction with Tirbanibulin 1% Ointment: A Clinical Perspective on Actinic Keratoses
2023-01-01 Campione, E; Rivieccio, A; Gaeta Shumak, R; Costanza, G; Cosio, T; Lambiase, S; Garofalo, V; Artosi, F; Lozzi, F; Freni, C; Romeo, A; Dika, E; Falconi, M; Bianchi, L
Prevalence of fungal colonization among patients with psoriasis in difficult-to-treat areas: impact of apremilast on mycotic burden and clinical outcomes
2024-01-01 Campione, E; Cosio, T; Pistoia, Es; Artosi, F; Shumack, Rg; Borselli, C; Rivieccio, A; Caputo, V; Favaro, M; Sorge, R; Pica, F; Bianchi, L; Gaziano, R
Role of Nicotinamide in the Pathogenesis of Actinic Keratosis: Implications for NAD+/SIRT1 Pathway
2024-01-01 Belardi, R; Pacifici, F; Cosio, T; Lambiase, S; GAETA SHUMAK, R; Artosi, F; Rivieccio, A; Cavalloro, D; Dellambra, E; Bianchi, L; Della-Morte, D; Campione, E
Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
---|---|---|---|---|
1-gen-2024 | Apremilast as a Potential Targeted Therapy for Metabolic Syndrome in Patients with Psoriasis: An Observational Analysis | Campione, E; Zarabian, N; Cosio, T; Borselli, C; Artosi, F; Cont, R; Sorge, R; GAETA SHUMAK, R; Costanza, G; Rivieccio, A; Gaziano, R; Bianchi, L | Articolo su rivista | |
1-dic-2025 | Bimekizumab for the treatment of moderate to severe psoriasis: a real-world experience over 52 weeks from two Italian dermatology clinics | Mortato, E; Artosi, F; Borselli, C; Compagnucci, I; Rivieccio, A; Lanna, C; Lambiase, S; Gaeta Shumak, R; Loconsole, F; Bianchi, L; Campione, E | Articolo su rivista | |
8-mag-2024 | Clinical and ultrasound efficacy of topical hypertonic cream (Jovita Osmocell®) in the treatment of cellulite: a prospective, monocentric, double-blind, placebo-controlled study | Di Guardo, A; Solito, C; Cantisani, V; Rega, F; Gargano, L; Rossi, G; Musolff, N; Azzella, G; Paolino, G; Losco, L; Rivieccio, A; Campione, E; Bianchi, L; Nisticò, Sp; Pellacani, G; Cantisani, C | Articolo su rivista | |
1-gen-2023 | Preliminary Evidence of Efficacy, Safety, and Treatment Satisfaction with Tirbanibulin 1% Ointment: A Clinical Perspective on Actinic Keratoses | Campione, E; Rivieccio, A; Gaeta Shumak, R; Costanza, G; Cosio, T; Lambiase, S; Garofalo, V; Artosi, F; Lozzi, F; Freni, C; Romeo, A; Dika, E; Falconi, M; Bianchi, L | Articolo su rivista | |
1-gen-2024 | Prevalence of fungal colonization among patients with psoriasis in difficult-to-treat areas: impact of apremilast on mycotic burden and clinical outcomes | Campione, E; Cosio, T; Pistoia, Es; Artosi, F; Shumack, Rg; Borselli, C; Rivieccio, A; Caputo, V; Favaro, M; Sorge, R; Pica, F; Bianchi, L; Gaziano, R | Articolo su rivista | |
1-gen-2024 | Role of Nicotinamide in the Pathogenesis of Actinic Keratosis: Implications for NAD+/SIRT1 Pathway | Belardi, R; Pacifici, F; Cosio, T; Lambiase, S; GAETA SHUMAK, R; Artosi, F; Rivieccio, A; Cavalloro, D; Dellambra, E; Bianchi, L; Della-Morte, D; Campione, E | Articolo su rivista |